Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines

doi:10.1186/1475-2867-6-2

Cancer Cell International

Volume 6

Viewing options:

Abstract
Full text
PDF (360KB)
Additional files

Associated material:

Related literature:

Articles citing this article
on BioMed Central
on Google Scholar
on PubMed Central
Other articles by authors
on Google Scholar

Chavez-Blanco A
Perez-Plasencia C
Perez-Cardenas E
Carrasco-Legleu C
Rangel-Lopez E
Segura-Pacheco B
Taja-Chayeb L
Trejo-Becerril C
Gonzalez-Fierro A
Candelaria M
Cabrera G
Duenas-Gonzalez A

on PubMed

Chavez-Blanco A
Perez-Plasencia C
Perez-Cardenas E
Carrasco-Legleu C
Rangel-Lopez E
Segura-Pacheco B
Taja-Chayeb L
Trejo-Becerril C
Gonzalez-Fierro A
Candelaria M
Cabrera G
Duenas-Gonzalez A
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Post to:

Primary research

Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines

Alma Chavez-Blanco¹^* , Carlos Perez-Plasencia¹^* , Enrique Perez-Cardenas¹ , Claudia Carrasco-Legleu¹ , Edgar Rangel-Lopez¹ , Blanca Segura-Pacheco¹ , Lucia Taja-Chayeb¹ , Catalina Trejo-Becerril¹ , Aurora Gonzalez-Fierro¹ , Myrna Candelaria² , Gustavo Cabrera¹ and Alfonso Duenas-Gonzalez¹